NCT02830321

Brief Summary

The purpose of this study to explore the association between Hyperemesis Gravidarum in pregnant women and Helicobacter pylori infection.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2015

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

July 3, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 12, 2016

Completed
Last Updated

July 12, 2016

Status Verified

July 1, 2016

Enrollment Period

9 months

First QC Date

July 3, 2016

Last Update Submit

July 11, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • The Association of Helicobacter Pylori in the Pathogenesis of Hyperemesis Gravidarum in Pregnant Women

    90 Participants were assessed by using H.p.S.Ag test to detect helicobacter infection in pregnant women

    from march 2015 to december 2015

Study Arms (2)

case

Pregnant women who suffered from hyperemesis gravidarum and admitted in the hospital * Age: 18-40 years old * Gestational age: less than 16 weeks confirmed by pelvic u/s * Excessive pregnancy - related nausea and /or vomiting that prevent adequate intake of food and fluids. All pregnant (case and control) were asked to bring a stool sample in a clean container. Collected samples were tested in a laboratory (Ain Shams Univerisity hospital). Stool samples were be tested by using one step H.pylori stool antigen test (CER TEST BIOTEC) for the detection of H. pylori antigen.

Other: helicopacter pylori stool antigen test (CER TEST BIOTEC)

control

Control patients which are selected from pregnant women presenting to the outpatient clinics for routine antenatal care of the same gestational age, same age range and same socioeconomic standard as cases.

Other: helicopacter pylori stool antigen test (CER TEST BIOTEC)

Interventions

Stool samples were tested by using one step H.pylori stool antigen test (CER TEST BIOTEC)for the detection of H. pylori antigen in pregnant women with hyperemesis gravidarum

Also known as: (CER TEST BIOTEC)
casecontrol

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Study will include pregnant women in the first trimester attending Ain Shams University Maternity Hospital antenatal clinic and admitted in the ward.

You may qualify if:

  • Age: 18-40 years old
  • Gestational age: less than 16 weeks confirmed by U/S
  • Excessive pregnancy - related nausea and /or vomiting that prevent adequate intake of food and fluids.
  • Measuring weight loss(\>5% of pre-pregnancy weight)
  • Signs of dehydration:
  • Ketonuria (+1 or more)
  • Hemoconcentration (normal Female hematocrit value (36.1-44.3%)

You may not qualify if:

  • Multiple gestation pregnancy
  • Hydatidiform molar pregnancy
  • Other causes of vomiting:
  • Gastroentritis
  • Cholecystitis
  • Pyelonephritis
  • Liver dysfunction

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Increased estrogen production causes decreased secretions of hydrochloric acids; therefore peptic ulcer formation or flare - up of existing peptic ulcers is uncommon during pregnancy and may improve (Winbery and Blaho, 2001).

    BACKGROUND

MeSH Terms

Conditions

Hyperemesis Gravidarum

Condition Hierarchy (Ancestors)

Morning SicknessPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesVomitingSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 3, 2016

First Posted

July 12, 2016

Study Start

March 1, 2015

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

July 12, 2016

Record last verified: 2016-07

Data Sharing

IPD Sharing
Will not share